Rheumatology medmal cases concentrate around missed GCA (vision loss), lupus nephritis workup delay, biologic-related opportunistic infections, ANCA vasculitis recognition, and scleroderma renal crisis. ACR + EULAR define the floors.
Try the 2-min Rheumatology demo → All specialtiesRheumatology cases turn on documented empiric steroids for suspected GCA (before biopsy), pre-biologic TB screening, lupus nephritis biopsy + treatment within weeks, and ACE inhibitor for scleroderma renal crisis regardless of renal function.
New headache + jaw claudication + age>50; ESR/CRP not checked OR steroids delayed; permanent vision loss.
TNFi/rituximab/JAKi without PJP prophylaxis or TB screening.
SLE with proteinuria; renal biopsy delayed; treatment delayed.
Sinusitis + hemoptysis + AKI; ANCA not checked.
Severe HTN + AKI in scleroderma; ACE held due to renal concerns.
No folate supplementation or CBC/LFT monitoring per ACR; pancytopenia.
For GCA cases: lock the witness into "I wanted biopsy confirmation," then juxtapose against ACR + EULAR standard that empiric high-dose steroids must be started immediately on clinical suspicion to prevent vision loss.
Why this lands: witness has framed diagnostic certainty as a substitute for vision-preserving empiric treatment.
Rheum cases turn on documented empiric steroids (GCA), pre-biologic screening, lupus nephritis biopsy timing, and SRC ACE-i. ACR + EULAR are real published floors.
ACR GCA Guideline, ACR Lupus Nephritis, ACR Biologics + Reproductive Health.
Yes. Expert-prep mode against your defense rheumatologist.
Bundled in MedLegal AI Pro ($49/mo), Professional ($249/mo), or Firm ($499/mo).
No signup, no mic. Cross-exam transfers to rheum — lock witness into the ACR empiric-treatment standards.
Run the 2-min demo → Start free 14-day trial